The state-of-the-art facility produces Edwards’s Carpentier-Edwards Perimount tissue heart valve replacements, and also serves as the headquarters for Edwards’s Asia-Pacific operations.
Donald Bobo, Jr, corporate vice president of heart valve therapy at Edwards, said: “Edwards’s new Singapore facility was developed to meet the global demands for our technologically advanced tissue heart valve replacement products. We look forward to serving more patients around the world through our heart valve operations in the US, Switzerland, and now, Singapore.”